|
Vi er bekendt med Danske Regioners ”Fællesregionale principper for efteruddannelse og kompetenceudvikling af regionernes sundhedspersonale”.
Hvis du skal have tilladelse fra f.eks. din afdelingsleder til at deltage, beder vi dig venligst selv sikre dette.
Hvis du ønsker adgang til den fulde invitation som indeholder tilmeldings information, beder vi dig kontakte din afdelingsledelse, som har denne.
Emerging COVID-19 vaccines bring hope to the world. They may also bring new questions to the clinicians who manage patients with severe asthma treated with immune modulating agents.
Will the treatment of severe asthma patients have an impact on protective immune response expected from vaccines? Are there any implications of the vaccines on the course of severe asthma? How may this reflect everyday clinicalpractice and what are the consequences for the patients?These, and more aspects, will be discussed by a renowned faculty during the webinar.
17.00 Opening
17.10 Principles of vaccination and new vaccine technologies
Prof. K. Lore, Karolinska Institutet, Sweden
17.30 Vaccination and immune-modulating agents (OCS and biologics) in severe asthma
Prof. J.C. Virchow, University Hospital Rostock, Germany
17.50 Implications for clinical practice
Prof. B. Lipworth, Scottish Centre for Respiratory Research, Ninewells Hospital, University of Dundee, Scotland
18.10 Panel discussion and Q&A